nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—CYP2D6—Carteolol—glaucoma	0.127	0.198	CbGbCtD
Vilazodone—CYP2D6—Betaxolol—glaucoma	0.086	0.134	CbGbCtD
Vilazodone—CYP2D6—Methazolamide—glaucoma	0.0652	0.102	CbGbCtD
Vilazodone—CYP3A4—Pilocarpine—glaucoma	0.0614	0.0956	CbGbCtD
Vilazodone—CYP2D6—Timolol—glaucoma	0.0554	0.0864	CbGbCtD
Vilazodone—CYP3A4—Brinzolamide—glaucoma	0.0482	0.075	CbGbCtD
Vilazodone—CYP2D6—Clonidine—glaucoma	0.0471	0.0735	CbGbCtD
Vilazodone—CYP3A4—Dorzolamide—glaucoma	0.0465	0.0725	CbGbCtD
Vilazodone—CYP3A4—Methazolamide—glaucoma	0.0414	0.0646	CbGbCtD
Vilazodone—CYP3A4—Acetazolamide—glaucoma	0.0331	0.0516	CbGbCtD
Vilazodone—CYP3A4—Clonidine—glaucoma	0.03	0.0467	CbGbCtD
Vilazodone—Dry mouth—Bimatoprost—glaucoma	0.000931	0.00261	CcSEcCtD
Vilazodone—Malnutrition—Brinzolamide—glaucoma	0.00093	0.00261	CcSEcCtD
Vilazodone—Dysgeusia—Dorzolamide—glaucoma	0.000926	0.0026	CcSEcCtD
Vilazodone—Nervous system disorder—Apraclonidine—glaucoma	0.000923	0.00259	CcSEcCtD
Vilazodone—Dysgeusia—Travoprost—glaucoma	0.000922	0.00259	CcSEcCtD
Vilazodone—Nervousness—Dorzolamide—glaucoma	0.000919	0.00258	CcSEcCtD
Vilazodone—Flatulence—Brinzolamide—glaucoma	0.000916	0.00257	CcSEcCtD
Vilazodone—Skin disorder—Apraclonidine—glaucoma	0.000914	0.00256	CcSEcCtD
Vilazodone—Asthenia—Levobunolol—glaucoma	0.000911	0.00256	CcSEcCtD
Vilazodone—Dysgeusia—Brinzolamide—glaucoma	0.000911	0.00255	CcSEcCtD
Vilazodone—Libido decreased—Timolol—glaucoma	0.000909	0.00255	CcSEcCtD
Vilazodone—Nervousness—Brinzolamide—glaucoma	0.000903	0.00253	CcSEcCtD
Vilazodone—Nervous system disorder—Bimatoprost—glaucoma	0.000895	0.00251	CcSEcCtD
Vilazodone—Convulsion—Acetazolamide—glaucoma	0.000894	0.00251	CcSEcCtD
Vilazodone—Vision blurred—Dorzolamide—glaucoma	0.000891	0.0025	CcSEcCtD
Vilazodone—Dizziness—Carteolol—glaucoma	0.000889	0.00249	CcSEcCtD
Vilazodone—Vision blurred—Travoprost—glaucoma	0.000887	0.00249	CcSEcCtD
Vilazodone—Skin disorder—Bimatoprost—glaucoma	0.000887	0.00249	CcSEcCtD
Vilazodone—Diarrhoea—Carbachol—glaucoma	0.000882	0.00247	CcSEcCtD
Vilazodone—Flatulence—Pilocarpine—glaucoma	0.000881	0.00247	CcSEcCtD
Vilazodone—Vision blurred—Brinzolamide—glaucoma	0.000876	0.00246	CcSEcCtD
Vilazodone—Palpitations—Brimonidine—glaucoma	0.000875	0.00245	CcSEcCtD
Vilazodone—Dysgeusia—Pilocarpine—glaucoma	0.000875	0.00245	CcSEcCtD
Vilazodone—Dizziness—Diclofenamide—glaucoma	0.000874	0.00245	CcSEcCtD
Vilazodone—Asthenia—Methazolamide—glaucoma	0.000873	0.00245	CcSEcCtD
Vilazodone—Tremor—Brinzolamide—glaucoma	0.000871	0.00244	CcSEcCtD
Vilazodone—Diarrhoea—Levobunolol—glaucoma	0.000869	0.00244	CcSEcCtD
Vilazodone—Nervousness—Pilocarpine—glaucoma	0.000868	0.00243	CcSEcCtD
Vilazodone—Nausea—Metipranolol—glaucoma	0.000862	0.00242	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.000858	0.00241	CcSEcCtD
Vilazodone—Agitation—Brinzolamide—glaucoma	0.000854	0.0024	CcSEcCtD
Vilazodone—Dizziness—Carbachol—glaucoma	0.000853	0.00239	CcSEcCtD
Vilazodone—Insomnia—Apraclonidine—glaucoma	0.000851	0.00239	CcSEcCtD
Vilazodone—Paraesthesia—Apraclonidine—glaucoma	0.000845	0.00237	CcSEcCtD
Vilazodone—Arthralgia—Brimonidine—glaucoma	0.000843	0.00236	CcSEcCtD
Vilazodone—Vision blurred—Pilocarpine—glaucoma	0.000842	0.00236	CcSEcCtD
Vilazodone—Vomiting—Diclofenamide—glaucoma	0.00084	0.00236	CcSEcCtD
Vilazodone—Dizziness—Levobunolol—glaucoma	0.00084	0.00236	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000837	0.00235	CcSEcCtD
Vilazodone—Tremor—Pilocarpine—glaucoma	0.000837	0.00235	CcSEcCtD
Vilazodone—Somnolence—Apraclonidine—glaucoma	0.000837	0.00235	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Timolol—glaucoma	0.000836	0.00235	CcSEcCtD
Vilazodone—Palpitations—Dorzolamide—glaucoma	0.000836	0.00234	CcSEcCtD
Vilazodone—Diarrhoea—Methazolamide—glaucoma	0.000832	0.00233	CcSEcCtD
Vilazodone—Palpitations—Travoprost—glaucoma	0.000832	0.00233	CcSEcCtD
Vilazodone—Insomnia—Bimatoprost—glaucoma	0.000826	0.00232	CcSEcCtD
Vilazodone—Dry mouth—Brimonidine—glaucoma	0.000825	0.00231	CcSEcCtD
Vilazodone—Palpitations—Brinzolamide—glaucoma	0.000822	0.0023	CcSEcCtD
Vilazodone—Erectile dysfunction—Betaxolol—glaucoma	0.000821	0.0023	CcSEcCtD
Vilazodone—Agitation—Pilocarpine—glaucoma	0.000821	0.0023	CcSEcCtD
Vilazodone—Vomiting—Carbachol—glaucoma	0.00082	0.0023	CcSEcCtD
Vilazodone—Hallucination—Clonidine—glaucoma	0.000816	0.00229	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000813	0.00228	CcSEcCtD
Vilazodone—Fatigue—Apraclonidine—glaucoma	0.000812	0.00228	CcSEcCtD
Vilazodone—Somnolence—Bimatoprost—glaucoma	0.000811	0.00228	CcSEcCtD
Vilazodone—Arthralgia—Dorzolamide—glaucoma	0.000805	0.00226	CcSEcCtD
Vilazodone—Dyspepsia—Bimatoprost—glaucoma	0.000803	0.00225	CcSEcCtD
Vilazodone—Arthralgia—Travoprost—glaucoma	0.000802	0.00225	CcSEcCtD
Vilazodone—Nausea—Carteolol—glaucoma	0.000798	0.00224	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000796	0.00223	CcSEcCtD
Vilazodone—Nervous system disorder—Brimonidine—glaucoma	0.000793	0.00222	CcSEcCtD
Vilazodone—Arthralgia—Brinzolamide—glaucoma	0.000792	0.00222	CcSEcCtD
Vilazodone—Palpitations—Pilocarpine—glaucoma	0.00079	0.00222	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000788	0.00221	CcSEcCtD
Vilazodone—Dry mouth—Dorzolamide—glaucoma	0.000787	0.00221	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000786	0.00221	CcSEcCtD
Vilazodone—Skin disorder—Brimonidine—glaucoma	0.000785	0.0022	CcSEcCtD
Vilazodone—Nausea—Diclofenamide—glaucoma	0.000785	0.0022	CcSEcCtD
Vilazodone—Dry mouth—Travoprost—glaucoma	0.000784	0.0022	CcSEcCtD
Vilazodone—Dizziness—Latanoprost—glaucoma	0.000779	0.00218	CcSEcCtD
Vilazodone—Feeling abnormal—Apraclonidine—glaucoma	0.000776	0.00218	CcSEcCtD
Vilazodone—Dry mouth—Brinzolamide—glaucoma	0.000774	0.00217	CcSEcCtD
Vilazodone—Vomiting—Methazolamide—glaucoma	0.000773	0.00217	CcSEcCtD
Vilazodone—Eye disorder—Clonidine—glaucoma	0.000766	0.00215	CcSEcCtD
Vilazodone—Nausea—Carbachol—glaucoma	0.000766	0.00215	CcSEcCtD
Vilazodone—Breast disorder—Timolol—glaucoma	0.000762	0.00214	CcSEcCtD
Vilazodone—Cardiac disorder—Clonidine—glaucoma	0.000761	0.00213	CcSEcCtD
Vilazodone—Arthralgia—Pilocarpine—glaucoma	0.000761	0.00213	CcSEcCtD
Vilazodone—Paraesthesia—Acetazolamide—glaucoma	0.000756	0.00212	CcSEcCtD
Vilazodone—Nausea—Levobunolol—glaucoma	0.000754	0.00212	CcSEcCtD
Vilazodone—Nervous system disorder—Travoprost—glaucoma	0.000754	0.00211	CcSEcCtD
Vilazodone—Somnolence—Acetazolamide—glaucoma	0.000749	0.0021	CcSEcCtD
Vilazodone—Skin disorder—Travoprost—glaucoma	0.000746	0.00209	CcSEcCtD
Vilazodone—Hyperhidrosis—Dorzolamide—glaucoma	0.000746	0.00209	CcSEcCtD
Vilazodone—Nervous system disorder—Brinzolamide—glaucoma	0.000744	0.00209	CcSEcCtD
Vilazodone—Dyspepsia—Acetazolamide—glaucoma	0.000741	0.00208	CcSEcCtD
Vilazodone—Skin disorder—Brinzolamide—glaucoma	0.000737	0.00207	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000736	0.00207	CcSEcCtD
Vilazodone—Decreased appetite—Acetazolamide—glaucoma	0.000732	0.00205	CcSEcCtD
Vilazodone—Insomnia—Brimonidine—glaucoma	0.000731	0.00205	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000727	0.00204	CcSEcCtD
Vilazodone—Fatigue—Acetazolamide—glaucoma	0.000726	0.00204	CcSEcCtD
Vilazodone—Paraesthesia—Brimonidine—glaucoma	0.000726	0.00204	CcSEcCtD
Vilazodone—Nausea—Methazolamide—glaucoma	0.000723	0.00203	CcSEcCtD
Vilazodone—Somnolence—Brimonidine—glaucoma	0.000719	0.00202	CcSEcCtD
Vilazodone—Mental disorder—Clonidine—glaucoma	0.000718	0.00201	CcSEcCtD
Vilazodone—Dyspepsia—Brimonidine—glaucoma	0.000711	0.002	CcSEcCtD
Vilazodone—Hallucination—Betaxolol—glaucoma	0.00071	0.00199	CcSEcCtD
Vilazodone—Hyperhidrosis—Pilocarpine—glaucoma	0.000705	0.00198	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000703	0.00197	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Travoprost—glaucoma	0.0007	0.00196	CcSEcCtD
Vilazodone—Insomnia—Dorzolamide—glaucoma	0.000698	0.00196	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Brimonidine—glaucoma	0.000698	0.00196	CcSEcCtD
Vilazodone—Fatigue—Brimonidine—glaucoma	0.000697	0.00195	CcSEcCtD
Vilazodone—Feeling abnormal—Acetazolamide—glaucoma	0.000694	0.00195	CcSEcCtD
Vilazodone—Nervousness—Clonidine—glaucoma	0.000693	0.00194	CcSEcCtD
Vilazodone—Paraesthesia—Dorzolamide—glaucoma	0.000693	0.00194	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000691	0.00194	CcSEcCtD
Vilazodone—Insomnia—Brinzolamide—glaucoma	0.000686	0.00193	CcSEcCtD
Vilazodone—Somnolence—Dorzolamide—glaucoma	0.000686	0.00192	CcSEcCtD
Vilazodone—Paraesthesia—Brinzolamide—glaucoma	0.000681	0.00191	CcSEcCtD
Vilazodone—Dyspepsia—Dorzolamide—glaucoma	0.000679	0.00191	CcSEcCtD
Vilazodone—Dyspepsia—Travoprost—glaucoma	0.000676	0.0019	CcSEcCtD
Vilazodone—Asthenia—Apraclonidine—glaucoma	0.000675	0.00189	CcSEcCtD
Vilazodone—Somnolence—Brinzolamide—glaucoma	0.000675	0.00189	CcSEcCtD
Vilazodone—Vision blurred—Clonidine—glaucoma	0.000673	0.00189	CcSEcCtD
Vilazodone—Decreased appetite—Dorzolamide—glaucoma	0.000671	0.00188	CcSEcCtD
Vilazodone—Erectile dysfunction—Timolol—glaucoma	0.000671	0.00188	CcSEcCtD
Vilazodone—Tremor—Clonidine—glaucoma	0.000669	0.00188	CcSEcCtD
Vilazodone—Dyspepsia—Brinzolamide—glaucoma	0.000668	0.00187	CcSEcCtD
Vilazodone—Eye disorder—Betaxolol—glaucoma	0.000667	0.00187	CcSEcCtD
Vilazodone—Fatigue—Dorzolamide—glaucoma	0.000665	0.00187	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000664	0.00186	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Travoprost—glaucoma	0.000663	0.00186	CcSEcCtD
Vilazodone—Fatigue—Travoprost—glaucoma	0.000663	0.00186	CcSEcCtD
Vilazodone—Cardiac disorder—Betaxolol—glaucoma	0.000662	0.00186	CcSEcCtD
Vilazodone—Insomnia—Pilocarpine—glaucoma	0.00066	0.00185	CcSEcCtD
Vilazodone—Decreased appetite—Brinzolamide—glaucoma	0.00066	0.00185	CcSEcCtD
Vilazodone—Agitation—Clonidine—glaucoma	0.000656	0.00184	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000655	0.00184	CcSEcCtD
Vilazodone—Paraesthesia—Pilocarpine—glaucoma	0.000655	0.00184	CcSEcCtD
Vilazodone—Asthenia—Bimatoprost—glaucoma	0.000655	0.00184	CcSEcCtD
Vilazodone—Fatigue—Brinzolamide—glaucoma	0.000654	0.00184	CcSEcCtD
Vilazodone—Somnolence—Pilocarpine—glaucoma	0.000648	0.00182	CcSEcCtD
Vilazodone—Diarrhoea—Apraclonidine—glaucoma	0.000644	0.00181	CcSEcCtD
Vilazodone—Dyspepsia—Pilocarpine—glaucoma	0.000642	0.0018	CcSEcCtD
Vilazodone—Feeling abnormal—Dorzolamide—glaucoma	0.000636	0.00178	CcSEcCtD
Vilazodone—Decreased appetite—Pilocarpine—glaucoma	0.000634	0.00178	CcSEcCtD
Vilazodone—Feeling abnormal—Travoprost—glaucoma	0.000633	0.00178	CcSEcCtD
Vilazodone—Palpitations—Clonidine—glaucoma	0.000631	0.00177	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00063	0.00177	CcSEcCtD
Vilazodone—Feeling abnormal—Brinzolamide—glaucoma	0.000625	0.00175	CcSEcCtD
Vilazodone—Mental disorder—Betaxolol—glaucoma	0.000625	0.00175	CcSEcCtD
Vilazodone—Dizziness—Apraclonidine—glaucoma	0.000623	0.00175	CcSEcCtD
Vilazodone—Malnutrition—Betaxolol—glaucoma	0.000621	0.00174	CcSEcCtD
Vilazodone—Dysgeusia—Betaxolol—glaucoma	0.000608	0.00171	CcSEcCtD
Vilazodone—Arthralgia—Clonidine—glaucoma	0.000608	0.0017	CcSEcCtD
Vilazodone—Asthenia—Acetazolamide—glaucoma	0.000604	0.00169	CcSEcCtD
Vilazodone—Dizziness—Bimatoprost—glaucoma	0.000604	0.00169	CcSEcCtD
Vilazodone—Nervousness—Betaxolol—glaucoma	0.000603	0.00169	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000603	0.00169	CcSEcCtD
Vilazodone—Feeling abnormal—Pilocarpine—glaucoma	0.000601	0.00169	CcSEcCtD
Vilazodone—Vomiting—Apraclonidine—glaucoma	0.000599	0.00168	CcSEcCtD
Vilazodone—Dry mouth—Clonidine—glaucoma	0.000594	0.00167	CcSEcCtD
Vilazodone—Vision blurred—Betaxolol—glaucoma	0.000586	0.00164	CcSEcCtD
Vilazodone—Tremor—Betaxolol—glaucoma	0.000582	0.00163	CcSEcCtD
Vilazodone—Hallucination—Timolol—glaucoma	0.00058	0.00163	CcSEcCtD
Vilazodone—Asthenia—Brimonidine—glaucoma	0.00058	0.00163	CcSEcCtD
Vilazodone—Diarrhoea—Acetazolamide—glaucoma	0.000576	0.00162	CcSEcCtD
Vilazodone—Connective tissue disorder—Timolol—glaucoma	0.000573	0.00161	CcSEcCtD
Vilazodone—Nervous system disorder—Clonidine—glaucoma	0.000571	0.0016	CcSEcCtD
Vilazodone—Skin disorder—Clonidine—glaucoma	0.000566	0.00159	CcSEcCtD
Vilazodone—Hyperhidrosis—Clonidine—glaucoma	0.000563	0.00158	CcSEcCtD
Vilazodone—Nausea—Apraclonidine—glaucoma	0.000559	0.00157	CcSEcCtD
Vilazodone—Dizziness—Acetazolamide—glaucoma	0.000557	0.00156	CcSEcCtD
Vilazodone—Asthenia—Dorzolamide—glaucoma	0.000554	0.00155	CcSEcCtD
Vilazodone—Asthenia—Travoprost—glaucoma	0.000551	0.00155	CcSEcCtD
Vilazodone—Palpitations—Betaxolol—glaucoma	0.000549	0.00154	CcSEcCtD
Vilazodone—Eye disorder—Timolol—glaucoma	0.000545	0.00153	CcSEcCtD
Vilazodone—Asthenia—Brinzolamide—glaucoma	0.000544	0.00153	CcSEcCtD
Vilazodone—Nausea—Bimatoprost—glaucoma	0.000542	0.00152	CcSEcCtD
Vilazodone—Cardiac disorder—Timolol—glaucoma	0.000541	0.00152	CcSEcCtD
Vilazodone—Vomiting—Acetazolamide—glaucoma	0.000535	0.0015	CcSEcCtD
Vilazodone—Dizziness—Brimonidine—glaucoma	0.000534	0.0015	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Clonidine—glaucoma	0.000531	0.00149	CcSEcCtD
Vilazodone—Arthralgia—Betaxolol—glaucoma	0.000529	0.00148	CcSEcCtD
Vilazodone—Diarrhoea—Dorzolamide—glaucoma	0.000528	0.00148	CcSEcCtD
Vilazodone—Insomnia—Clonidine—glaucoma	0.000527	0.00148	CcSEcCtD
Vilazodone—Diarrhoea—Travoprost—glaucoma	0.000526	0.00147	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000525	0.00147	CcSEcCtD
Vilazodone—Asthenia—Pilocarpine—glaucoma	0.000523	0.00147	CcSEcCtD
Vilazodone—Paraesthesia—Clonidine—glaucoma	0.000523	0.00147	CcSEcCtD
Vilazodone—Diarrhoea—Brinzolamide—glaucoma	0.000519	0.00146	CcSEcCtD
Vilazodone—Somnolence—Clonidine—glaucoma	0.000518	0.00145	CcSEcCtD
Vilazodone—Dry mouth—Betaxolol—glaucoma	0.000517	0.00145	CcSEcCtD
Vilazodone—Mental disorder—Timolol—glaucoma	0.000511	0.00143	CcSEcCtD
Vilazodone—Dizziness—Dorzolamide—glaucoma	0.00051	0.00143	CcSEcCtD
Vilazodone—Dizziness—Travoprost—glaucoma	0.000508	0.00143	CcSEcCtD
Vilazodone—Malnutrition—Timolol—glaucoma	0.000508	0.00142	CcSEcCtD
Vilazodone—Decreased appetite—Clonidine—glaucoma	0.000506	0.00142	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Clonidine—glaucoma	0.000503	0.00141	CcSEcCtD
Vilazodone—Fatigue—Clonidine—glaucoma	0.000502	0.00141	CcSEcCtD
Vilazodone—Dizziness—Brinzolamide—glaucoma	0.000502	0.00141	CcSEcCtD
Vilazodone—Nausea—Acetazolamide—glaucoma	0.0005	0.0014	CcSEcCtD
Vilazodone—Diarrhoea—Pilocarpine—glaucoma	0.000499	0.0014	CcSEcCtD
Vilazodone—Nervous system disorder—Betaxolol—glaucoma	0.000497	0.00139	CcSEcCtD
Vilazodone—Dysgeusia—Timolol—glaucoma	0.000497	0.00139	CcSEcCtD
Vilazodone—Nervousness—Timolol—glaucoma	0.000493	0.00138	CcSEcCtD
Vilazodone—Skin disorder—Betaxolol—glaucoma	0.000493	0.00138	CcSEcCtD
Vilazodone—Vomiting—Dorzolamide—glaucoma	0.000491	0.00138	CcSEcCtD
Vilazodone—Hyperhidrosis—Betaxolol—glaucoma	0.00049	0.00138	CcSEcCtD
Vilazodone—Vomiting—Brinzolamide—glaucoma	0.000482	0.00135	CcSEcCtD
Vilazodone—Dizziness—Pilocarpine—glaucoma	0.000482	0.00135	CcSEcCtD
Vilazodone—Nausea—Brimonidine—glaucoma	0.00048	0.00135	CcSEcCtD
Vilazodone—Feeling abnormal—Clonidine—glaucoma	0.00048	0.00135	CcSEcCtD
Vilazodone—Vision blurred—Timolol—glaucoma	0.000478	0.00134	CcSEcCtD
Vilazodone—Vomiting—Pilocarpine—glaucoma	0.000464	0.0013	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000462	0.0013	CcSEcCtD
Vilazodone—Insomnia—Betaxolol—glaucoma	0.000459	0.00129	CcSEcCtD
Vilazodone—Nausea—Dorzolamide—glaucoma	0.000458	0.00129	CcSEcCtD
Vilazodone—Nausea—Travoprost—glaucoma	0.000456	0.00128	CcSEcCtD
Vilazodone—Paraesthesia—Betaxolol—glaucoma	0.000455	0.00128	CcSEcCtD
Vilazodone—Nausea—Brinzolamide—glaucoma	0.000451	0.00126	CcSEcCtD
Vilazodone—Palpitations—Timolol—glaucoma	0.000449	0.00126	CcSEcCtD
Vilazodone—Dyspepsia—Betaxolol—glaucoma	0.000446	0.00125	CcSEcCtD
Vilazodone—Decreased appetite—Betaxolol—glaucoma	0.000441	0.00124	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Betaxolol—glaucoma	0.000438	0.00123	CcSEcCtD
Vilazodone—Fatigue—Betaxolol—glaucoma	0.000437	0.00123	CcSEcCtD
Vilazodone—Nausea—Pilocarpine—glaucoma	0.000433	0.00122	CcSEcCtD
Vilazodone—Arthralgia—Timolol—glaucoma	0.000432	0.00121	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000429	0.0012	CcSEcCtD
Vilazodone—Dry mouth—Timolol—glaucoma	0.000423	0.00119	CcSEcCtD
Vilazodone—Asthenia—Clonidine—glaucoma	0.000418	0.00117	CcSEcCtD
Vilazodone—Feeling abnormal—Betaxolol—glaucoma	0.000418	0.00117	CcSEcCtD
Vilazodone—Nervous system disorder—Timolol—glaucoma	0.000406	0.00114	CcSEcCtD
Vilazodone—Skin disorder—Timolol—glaucoma	0.000402	0.00113	CcSEcCtD
Vilazodone—Hyperhidrosis—Timolol—glaucoma	0.0004	0.00112	CcSEcCtD
Vilazodone—Diarrhoea—Clonidine—glaucoma	0.000399	0.00112	CcSEcCtD
Vilazodone—Dizziness—Clonidine—glaucoma	0.000385	0.00108	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Timolol—glaucoma	0.000377	0.00106	CcSEcCtD
Vilazodone—Insomnia—Timolol—glaucoma	0.000375	0.00105	CcSEcCtD
Vilazodone—Paraesthesia—Timolol—glaucoma	0.000372	0.00104	CcSEcCtD
Vilazodone—Vomiting—Clonidine—glaucoma	0.00037	0.00104	CcSEcCtD
Vilazodone—Somnolence—Timolol—glaucoma	0.000368	0.00103	CcSEcCtD
Vilazodone—Dyspepsia—Timolol—glaucoma	0.000365	0.00102	CcSEcCtD
Vilazodone—Asthenia—Betaxolol—glaucoma	0.000364	0.00102	CcSEcCtD
Vilazodone—Decreased appetite—Timolol—glaucoma	0.00036	0.00101	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Timolol—glaucoma	0.000358	0.001	CcSEcCtD
Vilazodone—Fatigue—Timolol—glaucoma	0.000357	0.001	CcSEcCtD
Vilazodone—Diarrhoea—Betaxolol—glaucoma	0.000347	0.000973	CcSEcCtD
Vilazodone—Nausea—Clonidine—glaucoma	0.000346	0.00097	CcSEcCtD
Vilazodone—Feeling abnormal—Timolol—glaucoma	0.000341	0.000958	CcSEcCtD
Vilazodone—Dizziness—Betaxolol—glaucoma	0.000335	0.000941	CcSEcCtD
Vilazodone—Vomiting—Betaxolol—glaucoma	0.000322	0.000904	CcSEcCtD
Vilazodone—Nausea—Betaxolol—glaucoma	0.000301	0.000845	CcSEcCtD
Vilazodone—Asthenia—Timolol—glaucoma	0.000297	0.000834	CcSEcCtD
Vilazodone—Diarrhoea—Timolol—glaucoma	0.000283	0.000795	CcSEcCtD
Vilazodone—Dizziness—Timolol—glaucoma	0.000274	0.000768	CcSEcCtD
Vilazodone—Vomiting—Timolol—glaucoma	0.000263	0.000739	CcSEcCtD
Vilazodone—Nausea—Timolol—glaucoma	0.000246	0.00069	CcSEcCtD
Vilazodone—SLC6A4—Circadian rythm related genes—ATOH7—glaucoma	8.7e-05	0.0462	CbGpPWpGaD
Vilazodone—SLC6A4—Monoamine Transport—SLC6A1—glaucoma	8.04e-05	0.0427	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—LMX1B—glaucoma	6.87e-05	0.0365	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—ATOH7—glaucoma	5.32e-05	0.0283	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—LMX1B—glaucoma	4.78e-05	0.0254	CbGpPWpGaD
Vilazodone—CYP2C18—Tryptophan metabolism—CYP1B1—glaucoma	4.36e-05	0.0231	CbGpPWpGaD
Vilazodone—CYP2C18—FOXA1 transcription factor network—SOD1—glaucoma	4.02e-05	0.0214	CbGpPWpGaD
Vilazodone—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	3.59e-05	0.0191	CbGpPWpGaD
Vilazodone—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.52e-05	0.0187	CbGpPWpGaD
Vilazodone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	3.51e-05	0.0186	CbGpPWpGaD
Vilazodone—CYP2C18—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.48e-05	0.0185	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—OPN4—glaucoma	3.46e-05	0.0184	CbGpPWpGaD
Vilazodone—SLC6A4—NRF2 pathway—SLC6A13—glaucoma	3.26e-05	0.0173	CbGpPWpGaD
Vilazodone—CYP2C18—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.85e-05	0.0152	CbGpPWpGaD
Vilazodone—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	2.79e-05	0.0148	CbGpPWpGaD
Vilazodone—SLC6A4—NRF2 pathway—TXN—glaucoma	2.68e-05	0.0142	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—HDAC9—glaucoma	2.46e-05	0.0131	CbGpPWpGaD
Vilazodone—SLC6A4—NRF2 pathway—SLC6A1—glaucoma	2.39e-05	0.0127	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	2.16e-05	0.0115	CbGpPWpGaD
Vilazodone—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	2.15e-05	0.0114	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—OPN4—glaucoma	2.12e-05	0.0113	CbGpPWpGaD
Vilazodone—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	2.06e-05	0.0109	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	1.98e-05	0.0105	CbGpPWpGaD
Vilazodone—SLC6A4—NRF2 pathway—TGFB2—glaucoma	1.95e-05	0.0103	CbGpPWpGaD
Vilazodone—CYP2C18—FOXA1 transcription factor network—CDKN1B—glaucoma	1.93e-05	0.0102	CbGpPWpGaD
Vilazodone—CYP2C18—Biological oxidations—GSTT1—glaucoma	1.9e-05	0.0101	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	1.9e-05	0.0101	CbGpPWpGaD
Vilazodone—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	1.82e-05	0.00968	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	1.78e-05	0.00945	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—NTRK2—glaucoma	1.76e-05	0.00936	CbGpPWpGaD
Vilazodone—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	1.74e-05	0.00925	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	1.74e-05	0.00922	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—HDAC9—glaucoma	1.71e-05	0.00911	CbGpPWpGaD
Vilazodone—SLC6A4—Monoamine Transport—TNF—glaucoma	1.7e-05	0.00901	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	1.69e-05	0.00899	CbGpPWpGaD
Vilazodone—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	1.65e-05	0.00875	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	1.56e-05	0.0083	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	1.52e-05	0.0081	CbGpPWpGaD
Vilazodone—CYP2C18—Biological oxidations—CYP1B1—glaucoma	1.52e-05	0.00805	CbGpPWpGaD
Vilazodone—CYP2C18—Metapathway biotransformation—CYP1B1—glaucoma	1.5e-05	0.00794	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	1.49e-05	0.0079	CbGpPWpGaD
Vilazodone—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	1.42e-05	0.00752	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	1.34e-05	0.00711	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NARFL—glaucoma	1.33e-05	0.00708	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CA5A—glaucoma	1.33e-05	0.00708	CbGpPWpGaD
Vilazodone—SLC6A4—NRF2 pathway—GSTM1—glaucoma	1.32e-05	0.00703	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—BDNF—glaucoma	1.31e-05	0.00698	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—OPN4—glaucoma	1.29e-05	0.00685	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—IL1A—glaucoma	1.26e-05	0.0067	CbGpPWpGaD
Vilazodone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	1.24e-05	0.00658	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—NGFR—glaucoma	1.23e-05	0.00655	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—NTRK2—glaucoma	1.23e-05	0.00652	CbGpPWpGaD
Vilazodone—CYP2C18—Biological oxidations—GSTM1—glaucoma	1.21e-05	0.00644	CbGpPWpGaD
Vilazodone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.2e-05	0.00639	CbGpPWpGaD
Vilazodone—CYP2C18—Metapathway biotransformation—GSTM1—glaucoma	1.2e-05	0.00635	CbGpPWpGaD
Vilazodone—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.19e-05	0.00631	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—NTRK1—glaucoma	1.17e-05	0.00623	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—NGF—glaucoma	1.17e-05	0.0062	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—NR3C1—glaucoma	1.16e-05	0.00617	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—PTGFR—glaucoma	1.16e-05	0.00617	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—OPN4—glaucoma	1.13e-05	0.00601	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—PTGFR—glaucoma	1.02e-05	0.00541	CbGpPWpGaD
Vilazodone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.75e-06	0.00518	CbGpPWpGaD
Vilazodone—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	9.73e-06	0.00517	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—FAS—glaucoma	9.19e-06	0.00488	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—BDNF—glaucoma	9.16e-06	0.00487	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—IL1A—glaucoma	8.8e-06	0.00467	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—NGF—glaucoma	8.13e-06	0.00432	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—NR3C1—glaucoma	8.09e-06	0.0043	CbGpPWpGaD
Vilazodone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.87e-06	0.00418	CbGpPWpGaD
Vilazodone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.76e-06	0.00412	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—NGFR—glaucoma	7.55e-06	0.00401	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—OPN4—glaucoma	7.29e-06	0.00387	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—NTRK1—glaucoma	7.17e-06	0.00381	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—OPN4—glaucoma	6.62e-06	0.00351	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PTGFR—glaucoma	6.56e-06	0.00348	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CA1—glaucoma	6.51e-06	0.00346	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—GSTT1—glaucoma	6.5e-06	0.00345	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—OPN4—glaucoma	6.4e-06	0.0034	CbGpPWpGaD
Vilazodone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.38e-06	0.00339	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CTSA—glaucoma	6.31e-06	0.00335	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PTGFR—glaucoma	5.96e-06	0.00316	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CA2—glaucoma	5.96e-06	0.00316	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—SMO—glaucoma	5.85e-06	0.00311	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—OPN4—glaucoma	5.81e-06	0.00309	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PTGFR—glaucoma	5.76e-06	0.00306	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LRP12—glaucoma	5.64e-06	0.003	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—FAS—glaucoma	5.62e-06	0.00298	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—VEGFA—glaucoma	5.57e-06	0.00296	CbGpPWpGaD
Vilazodone—HTR1A—G alpha (i) signalling events—C3—glaucoma	5.57e-06	0.00296	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PTGFR—glaucoma	5.23e-06	0.00278	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—CYP1B1—glaucoma	5.18e-06	0.00275	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—SMO—glaucoma	5.14e-06	0.00273	CbGpPWpGaD
Vilazodone—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	5.11e-06	0.00271	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	5.07e-06	0.00269	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LRP12—glaucoma	4.95e-06	0.00263	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—C3—glaucoma	4.89e-06	0.0026	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—TNF—glaucoma	4.78e-06	0.00254	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CA5A—glaucoma	4.56e-06	0.00242	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NARFL—glaucoma	4.56e-06	0.00242	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.45e-06	0.00236	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.43e-06	0.00235	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—GSTT1—glaucoma	4.25e-06	0.00226	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—TXN—glaucoma	4.2e-06	0.00223	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—GSTM1—glaucoma	4.14e-06	0.0022	CbGpPWpGaD
Vilazodone—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	4.09e-06	0.00217	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—OPN4—glaucoma	3.91e-06	0.00208	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.89e-06	0.00206	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.88e-06	0.00206	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—EDN1—glaucoma	3.86e-06	0.00205	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HEYL—glaucoma	3.63e-06	0.00193	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTGFR—glaucoma	3.52e-06	0.00187	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—TP53—glaucoma	3.44e-06	0.00183	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—OPN4—glaucoma	3.43e-06	0.00182	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—EDN1—glaucoma	3.39e-06	0.0018	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.39e-06	0.0018	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—C3—glaucoma	3.37e-06	0.00179	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.34e-06	0.00177	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—TNF—glaucoma	3.33e-06	0.00177	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTT1—glaucoma	3.25e-06	0.00173	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HEYL—glaucoma	3.19e-06	0.00169	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTGFR—glaucoma	3.09e-06	0.00164	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—SMO—glaucoma	3e-06	0.0016	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CA5A—glaucoma	2.98e-06	0.00158	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NARFL—glaucoma	2.98e-06	0.00158	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—C3—glaucoma	2.96e-06	0.00157	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RPTOR—glaucoma	2.75e-06	0.00146	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.71e-06	0.00144	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.67e-06	0.00142	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NCK2—glaucoma	2.67e-06	0.00142	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—SMO—glaucoma	2.64e-06	0.0014	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYP1B1—glaucoma	2.59e-06	0.00138	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ABCA1—glaucoma	2.59e-06	0.00138	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RPTOR—glaucoma	2.42e-06	0.00128	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NCK2—glaucoma	2.34e-06	0.00124	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HDAC9—glaucoma	2.27e-06	0.0012	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CA1—glaucoma	2.23e-06	0.00118	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—EDN1—glaucoma	2.18e-06	0.00116	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CTSA—glaucoma	2.16e-06	0.00114	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—TP53—glaucoma	2.1e-06	0.00112	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTM1—glaucoma	2.07e-06	0.0011	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CA2—glaucoma	2.04e-06	0.00108	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HDAC9—glaucoma	1.99e-06	0.00106	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—EDN1—glaucoma	1.98e-06	0.00105	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—EDN1—glaucoma	1.92e-06	0.00102	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—C3—glaucoma	1.91e-06	0.00101	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MTHFR—glaucoma	1.83e-06	0.000973	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SMO—glaucoma	1.77e-06	0.000943	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—EDN1—glaucoma	1.74e-06	0.000924	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—C3—glaucoma	1.73e-06	0.000919	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—APOE—glaucoma	1.71e-06	0.000906	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CAV1—glaucoma	1.69e-06	0.000898	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—C3—glaucoma	1.67e-06	0.000888	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NTRK2—glaucoma	1.62e-06	0.000862	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SMO—glaucoma	1.56e-06	0.000828	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—C3—glaucoma	1.52e-06	0.000807	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CA1—glaucoma	1.46e-06	0.000773	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TXN—glaucoma	1.43e-06	0.000762	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NTRK2—glaucoma	1.43e-06	0.000757	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CTSA—glaucoma	1.41e-06	0.000749	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NGFR—glaucoma	1.39e-06	0.00074	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CA2—glaucoma	1.33e-06	0.000707	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NTRK1—glaucoma	1.32e-06	0.000703	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NOS3—glaucoma	1.28e-06	0.000679	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NGFR—glaucoma	1.22e-06	0.000649	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN2B—glaucoma	1.22e-06	0.000648	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EDN1—glaucoma	1.17e-06	0.000621	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTGS2—glaucoma	1.17e-06	0.000621	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NTRK1—glaucoma	1.16e-06	0.000617	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTT1—glaucoma	1.11e-06	0.000591	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NGF—glaucoma	1.08e-06	0.000571	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN2B—glaucoma	1.07e-06	0.000569	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EDN1—glaucoma	1.03e-06	0.000546	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—C3—glaucoma	1.02e-06	0.000543	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOE—glaucoma	9.52e-07	0.000505	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NGF—glaucoma	9.44e-07	0.000501	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CAV1—glaucoma	9.43e-07	0.000501	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TXN—glaucoma	9.38e-07	0.000498	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—C3—glaucoma	8.97e-07	0.000477	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FN1—glaucoma	8.97e-07	0.000477	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—BAD—glaucoma	8.87e-07	0.000471	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP1B1—glaucoma	8.86e-07	0.000471	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ABCA1—glaucoma	8.86e-07	0.000471	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOE—glaucoma	8.36e-07	0.000444	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CAV1—glaucoma	8.28e-07	0.00044	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FN1—glaucoma	7.88e-07	0.000418	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BAD—glaucoma	7.79e-07	0.000413	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTT1—glaucoma	7.27e-07	0.000386	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOS3—glaucoma	7.13e-07	0.000379	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTM1—glaucoma	7.08e-07	0.000376	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—glaucoma	6.26e-07	0.000332	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOS3—glaucoma	6.26e-07	0.000332	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN1B—glaucoma	6.18e-07	0.000328	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOE—glaucoma	5.83e-07	0.00031	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP1B1—glaucoma	5.79e-07	0.000308	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCA1—glaucoma	5.79e-07	0.000308	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CAV1—glaucoma	5.77e-07	0.000307	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MMP9—glaucoma	5.72e-07	0.000304	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN1B—glaucoma	5.42e-07	0.000288	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VEGFA—glaucoma	5.14e-07	0.000273	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MMP9—glaucoma	5.02e-07	0.000267	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTM1—glaucoma	4.63e-07	0.000246	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VEGFA—glaucoma	4.51e-07	0.000239	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NOS3—glaucoma	4.37e-07	0.000232	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—glaucoma	4.09e-07	0.000217	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTGS2—glaucoma	3.99e-07	0.000212	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TP53—glaucoma	3.88e-07	0.000206	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOE—glaucoma	3.81e-07	0.000202	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CAV1—glaucoma	3.78e-07	0.000201	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TP53—glaucoma	3.41e-07	0.000181	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NOS3—glaucoma	2.85e-07	0.000152	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTGS2—glaucoma	2.61e-07	0.000139	CbGpPWpGaD
